Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis

Clinical Physiology and Functional Imaging

Volumn 29, Issue 2, 2009, Pages 136-142

  Cervin, Anders ^a,b,d,e   Wallwork, Ben ^a,b   Mackay sim, Alan ^a   Coman, William B ^b,c   Greiff, Lennart ^a,b,d  

^a GRIFFITH UNIVERSITY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e HELSINGBORG HOSPITAL   (Sweden)

Author keywords

2 macroglobulin; Chronic rhinosinusitis; Eosinophil cationic protein; Fucose; Interleukin 8; Myeloperoxidase

Indexed keywords

ALPHA 2 MACROGLOBULIN; CLARITHROMYCIN; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL CATIONIC PROTEIN 2; FUCOSE; HISTAMINE; INTERLEUKIN 8; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DRUG MEGADOSE; EOSINOPHIL; FEMALE; GRANULOCYTE; HUMAN; INFLAMMATION; LONG TERM CARE; LOW DRUG DOSE; MALE; MUCUS SECRETION; NEUTROPHIL CHEMOTAXIS; NOSE MUCUS; PRIORITY JOURNAL; RHINOSINUSITIS;

ADULT; ANTI-BACTERIAL AGENTS; AUSTRALIA; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; CLARITHROMYCIN; CYTOKINES; FEMALE; HISTAMINE; HISTAMINE AGONISTS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RHINITIS; SINUSITIS; TIME;

EID: 60149093233     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2008.00848.x     Document Type: Article

References (26)

1. Castells MT, Ballesta J, Madrid JF, Aviles M, Martinez-Menarguez JA. Characterization of glycoconjugates in developing rat respiratory system by means of conventional and lectin histochemistry. Histochemistry (1991); 95: 419-426.
2. Cervin A, Kalm O, Sandkull P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: Clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg (2002); 126: 481-489.
3. Demoly P, Crampette L, Mondain M, Enander I, Jones I, Bousquet J. Myeloperoxidase and interleukin-8 levels in chronic sinusitis. Clin Exp Allergy (1997); 27: 672-675.
4. Erger RA, Casale TB. Interleukin-8 plays a significant role in IgE-mediated lung inflammation. Eur Respir J (1998); 11: 299-305.
5. Freney M, Irth H, Lindberg H, Alkner U, Greiff L, Persson C, Andersson M, Marko-Varga G. Rapid screening of airway secretions for fucose by parallel ligand-exchange chromatography with post-column derivatization and fluorescence detection. Chromatographia (2001); 54: 439-445.
6. Greiff L, Pipkorn U, Alkner U, Persson CG. The 'nasal pool'device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy (1990); 20: 253-259.
7. Greiff L, Andersson M, Akerlund A, Wollmer P, Svensson C, Alkner U, Persson CG. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold. Thorax (1994); 49: 121-127.
8. Greiff L, Venge P, Andersson M, Enander I, Linden M, Myint S, Persson CG. Effects of rhinovirus-induced common colds on granulocyte activity in allergic rhinitis. J Infect (2002); 45: 227-232.
9. Greiff L, Andersson M, Erjefalt JS, Persson CG, Wollmer P. Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imaging (2003); 23: 301-306.
10. Greiff L, Andersson M, Coman WB, Lindberg H, Marko-Varga G, Wallwork B, Persson CG. Challenge-induced plasma exudation and mucinous secretion in human airways. Clin Physiol Funct Imaging (2005); 25: 241-245.
11. Hamilos DL, Leung DY, Wood R, Meyers A, Stephens JK, Barkans J, Meng Q, Cunningham L, Bean DK, Kay AB, Hamid Q. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol (1993); 92: 39-48.
12. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx (1996); 23: 48-56.
13. MacLeod CM, Hamid QA, Cameron L, Tremblay C, Brisco W. Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther (2001); 18: 75-82.
14. Mariassy AT, Plopper CG, St George JA, Wilson DW. Tracheobronchial epithelium of the sheep: IV. Lectin histochemical characterization of secretory epithelial cells. Anat Rec (1988); 222: 49-59.
15. Meyer P, Persson CG, Andersson M, Wollmer P, Linden M, Svensson C, Greiff L. Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis. Eur Respir J (1999); 13: 633-637.
16. Rogers DF. Airway goblet cells: Responsive and adaptable front-line defenders. Eur Respir J (1994); 7: 1690-1706.
17. Rudack C, Stoll W, Bachert C. Cytokines in nasal polyposis, acute and chronic sinusitis. Am J Rhinol (1998); 12: 383-388.
18. Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope (1997); 107: 1661-1666.
19. Suzuki H, Asada Y, Ikeda K, Oshima T, Takasaka T. Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. Laryngoscope (1999); 109: 407-410.
20. Svensson C, Andersson M, Greiff L, Alkner U, Persson CG. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy (1995); 25: 942-950.
21. Takeuchi N, Ichimura K. Status of long-term administration of macrolide antibiotics in small dosages: A survey based on questionnaires. Jpn J Antibiot (1997); 50(Suppl): 8-10.
22. Takeuchi K, Yuta A, Sakakura Y. Interleukin-8 gene expression in chronic sinusitis. Am J Otolaryngol (1995); 16: 98-102.
23. Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope (2002); 112: 1827-1830.
24. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope (2006); 116: 189-193.
25. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol (1993); 91: 1198-1205.
26. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol (2000); 14: 143-148.